TFO Wealth Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3
| Closed | -$15 | – | 135 |
|
2024
Q1 | $15 | Hold |
3
| – | – | ﹤0.01% | 776 |
|
2023
Q4 | $18 | Hold |
3
| – | – | ﹤0.01% | 920 |
|
2023
Q3 | $21 | Hold |
3
| – | – | ﹤0.01% | 1088 |
|
2023
Q2 | $21 | Hold |
3
| – | – | ﹤0.01% | 811 |
|
2023
Q1 | $25 | Buy |
3
+1
| +50% | +$8 | ﹤0.01% | 786 |
|
2022
Q4 | $160 | Buy |
+2
| New | +$160 | ﹤0.01% | 672 |
|